- Home
- GOSS vs ZVIA Comparison
GOSS vs ZVIA Comparison
Compare GOSS & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- ZVIA
- Stock Information
- Founded
- GOSS 2015
- ZVIA 2007
- Country
- GOSS United States
- ZVIA United States
- Employees
- GOSS N/A
- ZVIA N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- ZVIA Beverages (Production/Distribution)
- Sector
- GOSS Health Care
- ZVIA Consumer Staples
- Exchange
- GOSS Nasdaq
- ZVIA Nasdaq
- Market Cap
- GOSS 203.3M
- ZVIA 142.5M
- IPO Year
- GOSS 2019
- ZVIA 2021
- Fundamental
- Price
- GOSS $1.12
- ZVIA $3.08
- Analyst Decision
- GOSS Strong Buy
- ZVIA Hold
- Analyst Count
- GOSS 4
- ZVIA 3
- Target Price
- GOSS $7.50
- ZVIA $2.58
- AVG Volume (30 Days)
- GOSS 1.6M
- ZVIA 565.8K
- Earning Date
- GOSS 05-13-2025
- ZVIA 05-07-2025
- Dividend Yield
- GOSS N/A
- ZVIA N/A
- EPS Growth
- GOSS N/A
- ZVIA N/A
- EPS
- GOSS N/A
- ZVIA N/A
- Revenue
- GOSS $114,701,000.00
- ZVIA $154,273,000.00
- Revenue This Year
- GOSS N/A
- ZVIA $5.70
- Revenue Next Year
- GOSS $172.31
- ZVIA $7.10
- P/E Ratio
- GOSS N/A
- ZVIA N/A
- Revenue Growth
- GOSS N/A
- ZVIA N/A
- 52 Week Low
- GOSS $0.50
- ZVIA $0.62
- 52 Week High
- GOSS $1.55
- ZVIA $4.99
- Technical
- Relative Strength Index (RSI)
- GOSS 56.55
- ZVIA 71.32
- Support Level
- GOSS $1.06
- ZVIA $1.97
- Resistance Level
- GOSS $1.26
- ZVIA $2.37
- Average True Range (ATR)
- GOSS 0.11
- ZVIA 0.20
- MACD
- GOSS 0.04
- ZVIA 0.04
- Stochastic Oscillator
- GOSS 70.09
- ZVIA 90.24
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.